Skip to main content
Log in

Treatment of Crohn’s Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial

Digestive Diseases and Sciences Aims and scope Submit manuscript

Cite this article


Background and Aim

We previously reported an improvement in symptoms in Crohn’s disease following an IgG4-guided exclusion diet in an open-label study. We aimed to evaluate, in a double-blinded randomized sham-controlled setting, the efficacy of IgG4-guided diet in improving quality of life in patients with Crohn’s disease.


Consecutive patients with Crohn’s disease and a Crohn’s disease activity index (CDAI) of 80–400 attending tertiary and secondary care centers were screened. All patients had IgG4 titers tested against 16 common food types using ELISA. The true diet group excluded four food types with the highest antibody titers for 4 weeks, and the sham group excluded four foods with the lowest antibody titers. Quality of life was assessed using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) at beginning and end of the trial. Secondary outcome measures were CDAI, Harvey Bradshaw index, serum C-reactive protein, and fecal calprotectin.


One hundred and forty-five subjects were screened and 96 subjects had initial food antibody testing performed with 76 patients completing the study. Milk, beef, pork and egg were the most commonly excluded food types in the true diet group. There was a 3.05 (0.01–6.11) p < 0.05 improvement in SIBDQ and 41 (10.4–71.5) in CDAI p = 0.009.


IgG4-guided exclusion diet, as an adjunct, can improve quality of life and symptoms in patients with CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others


  1. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185–1191.

    Article  PubMed  Google Scholar 

  2. D’Souza S, Levy E, Mack D, et al. Dietary patterns and risk for Crohn’s disease in children. Inflamm Bowel Dis. 2008;14:367–373.

    Article  PubMed  Google Scholar 

  3. Greenberg GR. Nutritional support in inflammatory bowel disease: current status and future directions. Scand J Gastroenterol. 1992;192:117–122.

    Article  CAS  Google Scholar 

  4. Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007. doi:10.1002/14651858.CD005984.pub2.

  5. Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition for the maintenance of remission in Crohn’s disease: a systematic review. Eur J Gastroenterol Hepatol. 2010;22:1–8.

    Article  CAS  PubMed  Google Scholar 

  6. Alun Jones V, Workman E, Freeman H, et al. Crohn’s disease maintenance of remission by diet. Lancet. 1985;2:177–180.

    Article  Google Scholar 

  7. Van Den Bogaerde J, Cahill J, Emmanuel AV, et al. Gut mucosal response to food antigens in Crohn’s disease. Aliment Pharmacol Ther. 2002;16:1903–1915.

    Article  Google Scholar 

  8. Atkinson W, Sheldon T, Shaath N, et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53:1459–1464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gao ZH, McAlister VC, Wright JR Jr, et al. Immunoglobulin-G subclass antidonor reactivity in transplant recipients. Liver Transplant. 2004;10:1055–1059.

    Article  Google Scholar 

  10. Rajendran N, Kumar D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: a pilot study. Colorectal Dis. 2011;13:1009–1013.

    Article  CAS  PubMed  Google Scholar 

  11. Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162–169.

    Article  PubMed  Google Scholar 

  12. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s relapse prevention trial. Am J Gastroenterol. 1996;91:1571–1578.

    CAS  PubMed  Google Scholar 

  13. Kakodkar S, Azam JF, Mikolaitis SL, et al. The specific carbohydrate diet for inflammatory bowel disease: a case series. J Acad Nutr Diet. 2015;115:1226–1232.

    Article  PubMed  Google Scholar 

  14. Olendzki BC, Silverstein TD, Persuitte GM, et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:1–7.

    Article  Google Scholar 

  15. Chan D, Kumar D, Mendall M. What is known about the mechanisms of dietary influences in Crohn’s disease? Nutrition. 2015;31:1195–1203.

    Article  PubMed  Google Scholar 

  16. Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 1997;92:1148–1153.

    CAS  PubMed  Google Scholar 

  17. von Tirpitz C, Kohn C, Steinkamp M, et al. Lactose intolerance in active Crohn’s disease clinical value of duodenal lactase analysis. J Clin Gastroenterol. 2002;34:49–53.

    Article  Google Scholar 

  18. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106:563–573.

    Article  CAS  PubMed  Google Scholar 

  19. Teahon K, Smethurst P, Pearson M, et al. The effect of elemental diet on intestinal permeability and inflammation in Crohn’s disease. Gastroenterology. 1991;101:84–89.

    CAS  PubMed  Google Scholar 

  20. Pearson M, Teahon K, Levi AJ, et al. Food intolerance and Crohn’s disease. Gut. 1993;34:783–787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jacobsen MB, Aukrust P, Kittang E, et al. Relation between food provocation and systemic immune activation in patients with food intolerance. Lancet. 2000;356:400–401.

    Article  CAS  PubMed  Google Scholar 

  22. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56:524–535.

    Article  CAS  PubMed  Google Scholar 

  23. Ferguson A, Glen M, Ghosh S. Crohn’s disease: nutrition and nutritional therapy. Baillières Clin Gastroenterol. 1998;12:93–114.

    Article  CAS  PubMed  Google Scholar 

  24. Stapel SO, Asero R, Ballmer-Weber BK, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force report. Allergy. 2008;63:793–796.

    Article  CAS  PubMed  Google Scholar 

  25. Dvorak AM, Monahan RA, Osage JE, et al. Crohn’s disease: transmission electron microscopic studies: II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol. 1980;11:606–619.

    Article  CAS  PubMed  Google Scholar 

  26. Knutson L, Ahrenstedt O, Odlind B, et al. The jejunal secretion of histamine is increased in active Crohn’s disease. Gastroenterology. 1990;98:849–854.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Devinder Kumar.

Ethics declarations

Conflict of interest

The authors declare that there are no competing interests.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gunasekeera, V., Mendall, M.A., Chan, D. et al. Treatment of Crohn’s Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial. Dig Dis Sci 61, 1148–1157 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: